Esperion Announces Submissions of Two NDAs and Official Completion of Two MAA Validations for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet February 28, 2019 - NASDAQ Companies 0 » View More News for February 28, 2019
